<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39341876</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Clinical presentations, systemic inflammation response and ANDC scores in hospitalized patients with COVID-19.</ArticleTitle><Pagination><StartPage>22480</StartPage><MedlinePgn>22480</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22480</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-73001-x</ELocationID><Abstract><AbstractText>The association of anosmia/ageusia with a positive severe respiratory syndrome coronavirus 2 (SARS-CoV-2) test is well-established, suggesting these symptoms are reliable indicators of coronavirus disease 2019 (COVID-19) infection. This study investigates the clinical characteristics and systemic inflammatory markers in hospitalized COVID-19 patients in Taiwan, focusing on those with anosmia/ageusia. We conducted a retrospective observational study on 231 hospitalized COVID-19 patients (alpha variant) from April to July 2021. Clinical symptoms, dyspnea grading, and laboratory investigations, including neutrophil-lymphocyte ratios (NLRs), platelet-lymphocyte ratios (PLRs), and ANDC scores (an early warning score), were analyzed. Cough (64.1%), fever (58.9%), and dyspnea (56.3%) were the most common symptoms, while anosmia/ageusia affected 9% of patients. Those with anosmia/ageusia were younger, had lower BMI, lower systemic inflammatory markers, and better ANDC scores than those without these symptoms. Female patients exhibited lower NLR values and ANDC scores compared to male patients (all p &lt; 0.05). Multivariable regression analysis demonstrated significant associations between NLR and CRP and ferritin levels (all p &lt; 0.01), and between PLR and ESR and ferritin levels (p &lt; 0.01). Categorized ANDC scores significantly correlated with the total hospital length of stay (all p &lt; 0.05). Despite ethnic differences in the prevalence of anosmia/ageusia, our study highlights similar clinical presentations and inflammatory profiles to those observed in Western countries. The ANDC score effectively predicted hospital stay duration. These findings suggest that anosmia/ageusia may be associated with less severe disease and a lower inflammatory response, particularly in younger and female patients. The ANDC score can serve as a valuable prognostic tool in assessing the severity and expected hospital stay of COVID-19 patients.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Jung Lung</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Neurology, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation, New Taipei City, Taiwan. tulu@ms36.hinet.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Chang Gung Memorial Hospital at Linkou Medical Center and Chang Gung University College of Medicine, 5 Fu-Shin Street, Kwei-Shan, Taoyuan, 333, Taiwan. tulu@ms36.hinet.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Mind, Brain, &amp; Consciousness, Taipei Medical University, Taipei, Taiwan. tulu@ms36.hinet.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain &amp; Consciousness Research Center, Shuang Ho Hospital, New Taipei City, Taiwan. tulu@ms36.hinet.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mei-Chuen</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Nursing, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation, New Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsau</LastName><ForeName>Po-Wei</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Department of Neurology, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation, New Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Fu-Tsai</ForeName><Initials>FT</Initials><AffiliationInfo><Affiliation>Department of Thoracic Medicine, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Therapy, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Thoracic Medicine, Chang Gung Memorial Hospital at Linkou and School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shu-Min</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Thoracic Medicine, Chang Gung Memorial Hospital at Linkou and School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Mei-Lan</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>School of Nursing, Byrdine F. Lewis College of Nursing and Health Professions, Georgia State University, Atlanta, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ro</LastName><ForeName>Long-Sun</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chang Gung Memorial Hospital at Linkou Medical Center and Chang Gung University College of Medicine, 5 Fu-Shin Street, Kwei-Shan, Taoyuan, 333, Taiwan. cgrols@adm.cgmh.org.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>(CORPVVL0011)</GrantID><Agency>Chang Gung Memorial Hospital Research Fund</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="Y">Anosmia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000370" MajorTopicYN="N">Ageusia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="N">Systemic Inflammatory Response Syndrome</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ageusia</Keyword><Keyword MajorTopicYN="N">Anosmia</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Hospitalization</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>23</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39341876</ArticleId><ArticleId IdType="pmc">PMC11438960</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-73001-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-73001-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berlin, D. A., Gulick, R. M. &amp; Martinez, F. J. Severe Covid-19. N. Engl. J. Med.383, 2451–2460. 10.1056/NEJMcp2009575 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32412710</ArticleId></ArticleIdList></Reference><Reference><Citation>Alimohamadi, Y., Sepandi, M., Taghdir, M. &amp; Hosamirudsari, H. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. J. Prev. Med. Hyg.61, E304–E312. 10.15167/2421-4248/jpmh2020.61.3.1530 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7595075</ArticleId><ArticleId IdType="pubmed">33150219</ArticleId></ArticleIdList></Reference><Reference><Citation>Fotuhi, M., Mian, A., Meysami, S. &amp; Raji, C. A. Neurobiology of COVID-19. J. Alzheimers Dis.76, 3–19. 10.3233/JAD-200581 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7660990</ArticleId><ArticleId IdType="pubmed">32538857</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre, C. H. et al. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study. Lancet Digit. Health. 3, e577–e586. 10.1016/S2589-7500(21)00115-1 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8297994</ArticleId><ArticleId IdType="pubmed">34305035</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriatopoulou, M. et al. Organ-specific manifestations of COVID-19 infection. Clin. Exp. Med.20, 493–506. 10.1007/s10238-020-00648-x (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383117</ArticleId><ArticleId IdType="pubmed">32720223</ArticleId></ArticleIdList></Reference><Reference><Citation>Loganathan, S. et al. Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes. Respir. Physiol. Neurobiol.283, 103548. 10.1016/j.resp.2020.103548 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500408</ArticleId><ArticleId IdType="pubmed">32956843</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastug, A. et al. Clinical and laboratory features of COVID-19: predictors of severe prognosis. Int. Immunopharmacol.88, 106950. 10.1016/j.intimp.2020.106950 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7480980</ArticleId><ArticleId IdType="pubmed">32919217</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi, A., Shobeiri, P., Kulasinghe, A. &amp; Rezaei, N. Novel systemic inflammation markers to predict COVID-19 prognosis. Front. Immunol.12, 741061. 10.3389/fimmu.2021.741061 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8569430</ArticleId><ArticleId IdType="pubmed">34745112</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng, Z. et al. ANDC: an early warning score to predict mortality risk for patients with Coronavirus Disease 2019. J. Transl Med.18. 10.1186/s12967-020-02505-7 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7457219</ArticleId><ArticleId IdType="pubmed">32867787</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehanobish, E. et al. COVID-19-induced anosmia and ageusia are associated with younger age and lower blood eosinophil counts. Am. J. Rhinol. Allergy. 35, 830–839. 10.1177/19458924211004800 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8822197</ArticleId><ArticleId IdType="pubmed">33813917</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghobadi, H. et al. Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients. Front. Med.9, 916453, 10.3389/fmed.2022.916453 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9434555</ArticleId><ArticleId IdType="pubmed">36059829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong, J. Y., Wong, A., Zhu, D., Fastenberg, J. H. &amp; Tham, T. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and Meta-analysis. Otolaryngol. Head Neck Surg.163, 3–11. 10.1177/0194599820926473 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32369429</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, C. H., Faraji, F., Prajapati, D. P., Ostrander, B. T. &amp; DeConde, A. S. Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int. Forum Allergy Rhinol. 10, 821–831. 10.1002/alr.22592 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264572</ArticleId><ArticleId IdType="pubmed">32329222</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira, L. A. et al. Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? J. Laryngol. Otol.. 135, 723–728. 10.1017/S0022215121001651 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8267245</ArticleId><ArticleId IdType="pubmed">34184623</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bartheld, C. S. &amp; Wang, L. Prevalence of olfactory dysfunction with the omicron variant of SARS-CoV-2: a systematic review and meta-analysis. Cells 12. 10.3390/cells12030430 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9913864</ArticleId><ArticleId IdType="pubmed">36766771</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, A. A., Lee, S. W. Y., Lock, C. &amp; Keong, N. C. Geographical variations in host predisposition to COVID-19 related anosmia, Ageusia, and neurological syndromes. Front. Med.. 8, 661359. 10.3389/fmed.2021.661359 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8116582</ArticleId><ArticleId IdType="pubmed">33996863</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawi, A. &amp; Vasileva, D. Comparative profile for COVID-19 cases from China and North America: clinical symptoms, comorbidities and disease biomarkers. World J. Clin. Cases. 9, 118–132. 10.12998/wjcc.v9.i1.118 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7809676</ArticleId><ArticleId IdType="pubmed">33511177</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai, G. H. et al. Clinical features and characteristics of pediatric patients with COVID-19 infection: experiences in a Tertiary Taiwan Hospital. Medicine101, e30157. 10.1097/MD.0000000000030157 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9439632</ArticleId><ArticleId IdType="pubmed">36107524</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscutti, A. et al. Olfactory and gustatory dysfunctions in SARS-CoV-2 infection: a systematic review. Brain Behav. Immun. Health. 15, 100268. 10.1016/j.bbih.2021.100268 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129998</ArticleId><ArticleId IdType="pubmed">34027497</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien, J. R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur. Arch. Otorhinolaryngol.277, 2251–2261. 10.1007/s00405-020-05965-1 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud, M. et al. Clinical outcomes for patients with anosmia 1 year after COVID-19 diagnosis. JAMA Netw. Open.4, e2115352. 10.1001/jamanetworkopen.2021.15352 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226421</ArticleId><ArticleId IdType="pubmed">34165581</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bartheld, C. S., Hagen, M. M. &amp; Butowt, R. Prevalence of Chemosensory Dysfunction in COVID-19 patients: a systematic review and Meta-analysis reveals significant ethnic differences. ACS Chem. Neurosci.11, 2944–2961. 10.1021/acschemneuro.0c00460 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571048</ArticleId><ArticleId IdType="pubmed">32870641</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker, A., Kelly, C., Pottinger, G. &amp; Hopkins, C. Parosmia-a common consequence of covid-19. BMJ. 377, e069860. 10.1136/bmj-2021-069860 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35477684</ArticleId></ArticleIdList></Reference><Reference><Citation>Burges Watson, D. L. et al. Altered smell and taste: Anosmia, parosmia and the impact of long Covid-19. PLoS ONE. 16, e0256998. 10.1371/journal.pone.0256998 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8462678</ArticleId><ArticleId IdType="pubmed">34559820</ArticleId></ArticleIdList></Reference><Reference><Citation>Khurana, K. &amp; Singh, C. V. Management of anosmia in COVID-19: a comprehensive review. Cureus. 14, e30425. 10.7759/cureus.30425 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9670825</ArticleId><ArticleId IdType="pubmed">36407192</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo, E. G. M. et al. Association between chemosensory dysfunctions and inflammatory biomarkers in patients with SARS-CoV-2 infection: a systematic review and meta-analysis. Inflammopharmacology. 30, 2079–2087. 10.1007/s10787-022-01066-z (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9467422</ArticleId><ArticleId IdType="pubmed">36097300</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo, G. D. et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med.13. 10.1126/scitranslmed.abf8396 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Anca, P. S., Toth, P. P., Kempler, P. &amp; Rizzo, M. Gender differences in the battle against COVID-19: impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes. Int. J. Clin. Pract.75, e13666. 10.1111/ijcp.13666 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435574</ArticleId><ArticleId IdType="pubmed">32770758</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli, C. M. et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 369, (1966). 10.1136/bmj.m1966 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosidlo, J. W., Wolszczak-Biedrzycka, B., Matowicka-Karna, J., Dymicka-Piekarska, V. &amp; Dorf, J. Clinical significance and diagnostic utility of NLR, LMR, PLR and SII in the course of COVID-19: a literature review. J. Inflamm. Res.16, 539–562. 10.2147/JIR.S395331 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9930576</ArticleId><ArticleId IdType="pubmed">36818192</ArticleId></ArticleIdList></Reference><Reference><Citation>Avci, A., Ozer, M. R., Kucukceran, K. &amp; Yurdakul, M. S. Roles of CRP and neutrophil-to-lymphocyte ratio in the prediction of readmission of COVID-19 patients discharged from the ED. J. Acute Med.12, 131–138. 10.6705/j.jacme.202212_12(4).0001 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9815995</ArticleId><ArticleId IdType="pubmed">36761852</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddani, S. S., Gupta, N., Umakanth, S., Joylin, S. &amp; Saravu, K. Neutrophil-lymphocyte ratio in patients with COVID-19 as a simple tool to predict requirement of admission to a critical care unit. Indian J. Crit. Care Med.25, 535–539. 10.5005/jp-journals-10071-23801 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8196394</ArticleId><ArticleId IdType="pubmed">34177173</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar, S., Kannan, S., Khanna, P. &amp; Singh, A. K. Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: a systematic review and meta-analysis. J. Med. Virol.94, 211–221. 10.1002/jmv.27297 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661888</ArticleId><ArticleId IdType="pubmed">34436785</ArticleId></ArticleIdList></Reference><Reference><Citation>Beberashvili, I., Omar, M. A., Nizri, E., Stav, K. &amp; Efrati, S. Combined use of CRP with neutrophil-to-lymphocyte ratio in differentiating between infectious and noninfectious inflammation in hemodialysis patients. Sci. Rep.13, 5463. 10.1038/s41598-023-32270-8 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10071264</ArticleId><ArticleId IdType="pubmed">37016028</ArticleId></ArticleIdList></Reference><Reference><Citation>Man, M. A. et al. Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients. PLoS ONE. 16, e0252599. 10.1371/journal.pone.0252599 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238190</ArticleId><ArticleId IdType="pubmed">34181675</ArticleId></ArticleIdList></Reference><Reference><Citation>Taiwan Centers for Disease Control. Weekly Number of Suspected COVID-19 Cases Reported—By Sources, https://www.cdc.gov.tw/En (.</Citation></Reference><Reference><Citation>Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro. Surveill. 25. 10.2807/1560-7917.ES.2020.25.3.2000045 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6988269</ArticleId><ArticleId IdType="pubmed">31992387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendrick, K. R., Baxi, S. C. &amp; Smith, R. M. Usefulness of the modified 0–10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J. Emerg. Nurs.26, 216–222. 10.1016/s0099-1767(00)90093-x (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10839848</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilge, M., Akilli, I. K., Karaayvaz, E. B., Yesilova, A. &amp; Kart Yasar, K. Comparison of systemic immune-inflammation index (SII), early warning score (ANDC) and prognostic nutritional index (PNI) in hospitalized patients with malignancy, and their influence on mortality from COVID-19. Infect. Agent Cancer. 16, 60. 10.1186/s13027-021-00400-4 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441248</ArticleId><ArticleId IdType="pubmed">34526045</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, E. et al. A chest radiograph scoring system in patients with severe acute respiratory infection: a validation study. BMC Med. Imaging. 1510.1186/s12880-015-0103-y (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4696329</ArticleId><ArticleId IdType="pubmed">26714630</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai, K. C. et al. A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: a bedside-to-bench study. Biomed. Pharmacother. 133, 111037. 10.1016/j.biopha.2020.111037 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7676327</ArticleId><ArticleId IdType="pubmed">33249281</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>